Trial Outcomes & Findings for Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents (NCT NCT02216526)
NCT ID: NCT02216526
Last Updated: 2018-04-13
Results Overview
Clinical assessment of the presence or severity of skin dryness using a five point rating scale at right lower leg. The Overall Dry Skin score is a clinical assessment of the presence and severity of skin dryness using a five-point scale. A score of '0' indicates no skin dryness, whereas a score of '4' indicates advanced skin roughness, large scales, inflammation and cracks.
COMPLETED
NA
133 participants
Baseline; Day 56+/-4
2018-04-13
Participant Flow
completed, recruitment period: September 2014 to May 2015, nursing homes
Participant milestones
| Measure |
Cetaphil® Restoraderm
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Overall Study
STARTED
|
45
|
44
|
44
|
|
Overall Study
COMPLETED
|
40
|
41
|
36
|
|
Overall Study
NOT COMPLETED
|
5
|
3
|
8
|
Reasons for withdrawal
| Measure |
Cetaphil® Restoraderm
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Overall Study
Adverse Event
|
1
|
1
|
0
|
|
Overall Study
Death
|
0
|
1
|
3
|
|
Overall Study
Protocol Violation
|
2
|
0
|
2
|
|
Overall Study
Hospitalization
|
2
|
1
|
3
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Cetaphil® Restoraderm
n=45 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=44 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=44 Participants
Usual skin care routine of the nursing home resident
|
Total
n=133 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=45 Participants
|
0 Participants
n=44 Participants
|
0 Participants
n=44 Participants
|
0 Participants
n=133 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=45 Participants
|
0 Participants
n=44 Participants
|
0 Participants
n=44 Participants
|
0 Participants
n=133 Participants
|
|
Age, Categorical
>=65 years
|
45 Participants
n=45 Participants
|
44 Participants
n=44 Participants
|
44 Participants
n=44 Participants
|
133 Participants
n=133 Participants
|
|
Sex: Female, Male
Female
|
25 Participants
n=45 Participants
|
32 Participants
n=44 Participants
|
30 Participants
n=44 Participants
|
87 Participants
n=133 Participants
|
|
Sex: Female, Male
Male
|
20 Participants
n=45 Participants
|
12 Participants
n=44 Participants
|
14 Participants
n=44 Participants
|
46 Participants
n=133 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
Germany
|
45 participants
n=45 Participants
|
44 participants
n=44 Participants
|
44 participants
n=44 Participants
|
133 participants
n=133 Participants
|
PRIMARY outcome
Timeframe: Baseline; Day 56+/-4Population: At Day 56 +/- 3 data of two participants to calculate the Change from Baseline to Day 56 +/-3 were missing. In Group I (Cetaphil) 39/40 participants were analyzed. In Group III (Standard Skin care) 35/36 participants were analyzed.
Clinical assessment of the presence or severity of skin dryness using a five point rating scale at right lower leg. The Overall Dry Skin score is a clinical assessment of the presence and severity of skin dryness using a five-point scale. A score of '0' indicates no skin dryness, whereas a score of '4' indicates advanced skin roughness, large scales, inflammation and cracks.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=39 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=41 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=35 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Change From Baseline in Overall Dry Skin Score (ODS)
|
-0.9 units on a scale
Standard Deviation 1.9
|
-1.2 units on a scale
Standard Deviation 1.1
|
-0.9 units on a scale
Standard Deviation 1.0
|
SECONDARY outcome
Timeframe: Baseline, Day 56 +/- 4Population: At Day 56 +/- 3 data of four participants to calculate the change from Baseline to Day 56 +/-3 were missing. In Group I (Cetaphil) 39/40 participants were analyzed. In Group II (Excipial) 40/41 participants were analyzed. In Group III (Standard Skin care) 34/36 participants were analyzed.
Change in Stratum corneum hydration (SCH) at the lower leg. Instrumental skin measurements were conducted to characterize possible effects of the interventions in terms of skin function. The stratum corneum hydration was measured using the Corneometer CM 825 (Courage + Khazaka, Cologne, Germany). This measurement is based on the differences of the dielectric constant of water and other substances. With this device, only the moisture content in the stratum corneum is measured. The arbitrary units (a.u.) range from 0 to 120 where as higher readings indicate higher stratum corneum hydration.Values \> 40 a.u. are often considered 'normal', whereas values \< 40 a.u. are regarded as typical for dry Skin.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=39 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=40 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=34 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Stratum Corneum Hydration (SCH)
|
2.8 arbitrary units
Standard Deviation 8.9
|
1.6 arbitrary units
Standard Deviation 10.1
|
2.0 arbitrary units
Standard Deviation 8.9
|
SECONDARY outcome
Timeframe: Baseline, Day 56 +/- 4Population: At Day 56 +/- 3 data of twelve participants to calculate the change from Baseline to Day 56 +/-3 were missing. In Group I (Cetaphil) 36/40 participants were analyzed. In Group II (Excipial) 38/41 participants were analyzed. In Group III (Standard Skin care) 31/36 participants were analyzed.
Change in Transepidermal water loss (TEWL) at the lower leg. Transepidermal water loss was measured with the Tewameter TM 300 (Courage + Khazaka, Cologne, Germany). The probe captures the constant permeation of water through the stratum corneum in gram per hour per m2. The measuring probe contains a pair of sensors that are located in different distances to the skin surface to determine temperature and relative humidity above the skin surface. The humidity gradient between both sensors is used for calculating the transepidermal water loss. Higher values indicate a higher transepidermal water loss.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=36 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=38 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=31 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Transepidermal Water Loss (TEWL)
|
1.8 g/m2/h
Standard Deviation 11.4
|
1.4 g/m2/h
Standard Deviation 12.3
|
3.4 g/m2/h
Standard Deviation 7.0
|
SECONDARY outcome
Timeframe: Baseline, Day 56 +/- 4Population: At Day 56 +/- 3 data of six participants to calculate the change from Baseline to Day 56 +/-3 were missing. In Group I (Cetaphil) 39/40 participants were analyzed. In Group II (Excipial) 40/41 participants were analyzed. In Group III (Standard Skin care) 32/36 participants were analyzed.
Changes in Skin surface pH at the lower leg. Skin surface pH was measured with the Skin-pH-Meter PH 905 (Courage + Khazaka, Cologne, Germany), a planar glass electrode. The pH is a measure of acidity and alkalinity of a solution and it indicates the concentration of the hydrogen ions in an aqueous solution. Reference values of human skin have been reported to range from 4 to 6.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=39 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=40 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=32 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Skin Surface pH
|
0.07 units on a scale
Standard Deviation 0.7
|
0.3 units on a scale
Standard Deviation 0.8
|
0.1 units on a scale
Standard Deviation 0.7
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only participants not being cognitively impaired were able to answer the questionnaires (in total n = 32/133 at baseline).
Self-completion of the 5-D itch scale. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=9 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 1. Hours of Itching (1 = Less Than 6 Hours/Day; 2 = 6-12 Hours/Day; 3 = 12-18 Hours/Day; 4 = 18-23hours/Day; 5 = All Day) at Baseline
|
1.3 units on a scale
Standard Deviation 1.1
|
1.0 units on a scale
Standard Deviation 0.0
|
1.0 units on a scale
Standard Deviation 0.0
|
SECONDARY outcome
Timeframe: BaselineClinical assessment of the presence of a pressure ulcer.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=45 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=44 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=44 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Number of Participants With a Pressure Ulcer at Baseline
|
2 Participants
|
7 Participants
|
3 Participants
|
SECONDARY outcome
Timeframe: BaselineClinical assessment of the presence of incontinence associated dermatitis according to the IAD-IT classification
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=45 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=44 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=44 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Number of Participants With Incontinence Associated Dermatitis (IAD) at Baseline
|
16 Participants
|
19 Participants
|
12 Participants
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only participants not being cognitively impaired were able to answer the questionnaires (in total n = 32/133 at baseline).
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=9 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 1. Light Sleep (0) - Deep Sleep (10) at Baseline
|
6.1 units on a scale
Standard Deviation 3.9
|
7.1 units on a scale
Standard Deviation 2.9
|
6.2 units on a scale
Standard Deviation 2.9
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only residents being cognitively not impaired were able to answer the questionnaires (At baseline n = 32/133)
Self-completion of the WHO-Five Well-being Index. Well-being was assessed with the WHO-Five Well-being Index. The German version of the questionnaire published by the World Health Organization in 1998 was used. Scores range from '5' (all the time) to '0' (never) for in total five items. Simple questions were asked regarding well-being in the last two weeks, e.g. 'In the last two weeks … I was happy' or '…I was relaxed'. The sum scores range from 0, indicating the lowest well-being, to 25, indicating the highest well-being. A cut-off score of \< 13 is recommended. The validity and reliability of the questionnaire was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=9 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Life Sum Score at Baseline
|
16.42 units on a scale
Standard Deviation 4.69
|
18.33 units on a scale
Standard Deviation 4.18
|
11.09 units on a scale
Standard Deviation 7.37
|
SECONDARY outcome
Timeframe: Day 28 +/-3Population: After 4 weeks of the study, in total n= 13 participants were loss to follow up.
Clinical assessment of the presence of pressure ulcer.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=41 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=42 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=37 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Number of Participants With Pressure Ulcer at Day 28 +/-3
|
1 Participants
|
3 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: At the end of the study, in total n = 16 participants were loss to follow up.
Clinical assessment of the presence of a pressure ulcer.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=40 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=41 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=36 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Number of Participants With Pressure Ulcer at Day 56 +/-3
|
2 Participants
|
3 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: BaselineClinical assessment of the presence of skin tears according to the STAR Classification
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=45 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=44 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=44 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Number of Participants With Skin Tears at Baseline
|
2 Participants
|
1 Participants
|
5 Participants
|
SECONDARY outcome
Timeframe: Day 28 +/-3Population: In total n = 13 participants were loss to follow up after 4 weeks.
Clinical assessment aof the presence of skin tears according to the STAR Classification
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=41 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=42 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=37 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Number of Participants With Skin Tears at Day 28 +/-3
|
1 Participants
|
1 Participants
|
4 Participants
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: In total n = 16 participants were loss to follow up after eight weeks (end of the study).
Clinical assessment aof the presence of skin tears according to the STAR Classification
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=40 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=41 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=36 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Number of Participants With Skin Tears at Day 56 +/-3
|
2 Participants
|
0 Participants
|
3 Participants
|
SECONDARY outcome
Timeframe: Day 28 +/-3Population: In total n = 13 participants were loss to follow up after 4 weeks.
Clinical assessment of the presence and/or severity of incontinence associated dermatitis according to the IAD-IT classification
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=41 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=42 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=47 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Number of Participants With Incontinence Associated Dermatitis (IAD) at Day 28 +/-3
|
20 Participants
|
18 Participants
|
21 Participants
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: In total n = 16 participants were loss to follow up after eight weeks (end of the study).
Clinical assessment of the presence and/or severity of incontinence associated dermatitis according to the IAD-IT classification
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=40 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=41 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=36 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Number of Participants With Incontinence Associated Dermatitis (IAD) at Day 56 +/-3
|
8 Participants
|
13 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only residents being cognitively not impaired were able to answer the questionnaires (in total n = 28/117 at the end of the study).
Self-completion of the WHO-Five Well-being Index. Well-being was assessed with the WHO-Five Well-being Index. The German version of the questionnaire published by the World Health Organization in 1998 was used. Scores range from '5' (all the time) to '0' (never) for in total five items. Simple questions were asked regarding well-being in the last two weeks, e.g. 'In the last two weeks … I was happy' or '…I was relaxed'. The sum scores range from 0, indicating the lowest well-being, to 25, indicating the highest well-being. A cut-off score of \< 13 is recommended. The validity and reliability of the questionnaire was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Life Sum Score at Day 56 +/-3
|
17.55 units on a scale
Standard Deviation 5.22
|
19.00 units on a scale
Standard Deviation 5.76
|
14.00 units on a scale
Standard Deviation 5.52
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only residents being not cognitively impaired were able to answer the questionnaires (in total n = 32/133).
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=9 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 2. Never Fall Asleep (0) - Immediately Fall Asleep (10) at Baseline
|
6.8 units on a scale
Standard Deviation 3.7
|
7.2 units on a scale
Standard Deviation 3.4
|
6.5 units on a scale
Standard Deviation 3.2
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only residents being not cognitively impaired were able to answer the questionnaires (in total n = 32/133 at baseline).
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=9 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 3. Awake All Night (0) - Awake Very Little (10) at Baseline
|
7.6 units on a scale
Standard Deviation 2.6
|
8.4 units on a scale
Standard Deviation 2.1
|
7.0 units on a scale
Standard Deviation 2.6
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only residents being not cognitively impaired were able to answer the questionnaires (in total 32/133 at baseline).
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=9 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 4. Not Back to Sleep (0) - Back to Sleep Immediately (10) at Baseline
|
7.1 units on a scale
Standard Deviation 3.9
|
8.4 units on a scale
Standard Deviation 2.3
|
7.8 units on a scale
Standard Deviation 3.0
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only residents not being cognitively impaired were able to answer the questionnaires (in total n = 32/133 at baseline)
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=9 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 5. Bad Sleep (0) - Good Sleep (10) at Baseline
|
7.1 units on a scale
Standard Deviation 2.9
|
7.5 units on a scale
Standard Deviation 2.8
|
7.0 units on a scale
Standard Deviation 2.9
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only residents not being cognitively impaired were able to answer the questionnaires. Due to loss to follow up only n = 28/117 participants were able to answer at the end of the study.
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 1. Light Sleep (0) - Deep Sleep (10) at Day 56 +/-3
|
7.1 units on a scale
Standard Deviation 2.9
|
7.9 units on a scale
Standard Deviation 2.2
|
7.4 units on a scale
Standard Deviation 2.8
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only residents not being cognitively impaired were able to answer the questionnaires. Due to loss to follow up only n = 28/117 participants were able to answer at the end of the study.
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=99 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 2. Never Fall Asleep (0) - Immediately Fall Asleep (10) at Day 56 +/-3
|
7.9 units on a scale
Standard Deviation 2.9
|
7.1 units on a scale
Standard Deviation 2.8
|
8.0 units on a scale
Standard Deviation 2.8
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only residents not being cognitively impaired were able to answer the questionnaires. Due to loss to follow up only n = 28/117 participants were able to answer at the end of the study.
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 3. Awake All Night (0) - Awake Very Little (10) at Day 56 +/-3
|
6.9 units on a scale
Standard Deviation 2.9
|
7.5 units on a scale
Standard Deviation 2.1
|
7.1 units on a scale
Standard Deviation 2.5
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only residents not being cognitively impaired were able to answer the questionnaires. Due to loss to follow up only n = 28/117 participants were able to answer at the end of the study.
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 4. Not Back to Sleep (0) - Back to Sleep Immediately (10) at Day 56 +/-3
|
6.6 units on a scale
Standard Deviation 3.4
|
9.3 units on a scale
Standard Deviation 0.6
|
7.8 units on a scale
Standard Deviation 3.1
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only residents not being cognitively impaired were able to answer the questionnaires. Due to loss to follow up only n = 28/117 participants were able to answer at the end of the study.
Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ).Sleep quality was assessed with the Pittsburgh Richard Campbell Sleep Quality Assessment. Five questions were asked regarding the sleep quality for the last night via 0-100mm visual analogue scales. The interrater reliability and the most usefulness was recently supported.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Quality of Sleep. Question 5. Bad Sleep (0) - Good Sleep (10) at Day 56 +/-3
|
7.3 units on a scale
Standard Deviation 3.1
|
8.1 units on a scale
Standard Deviation 2.3
|
7.7 units on a scale
Standard Deviation 2.8
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only participants not being cognitively impaired were able to answer the questionnaires (in total n = 32/133 at baseline).
Self-completion of the 5-D itch scale. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=9 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 2. Itch Intensity (1 = Not Present; 2 = Mild; 3 = Moderate; 4 = Severe; 5 = Unbearable) at Baseline
|
1.6 units on a scale
Standard Deviation 0.7
|
2.0 units on a scale
Standard Deviation 1.0
|
1.9 units on a scale
Standard Deviation 0.9
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only participants not being cognitively impaired were able to answer the quastionnaires (in total n = 32/133 at baseline). One value in the Excipial Group is missing for this question.
Self-completion of the 5-D itch scale. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 3. Changes in Intensity of Itch (Past Two Weeks). (1 = Completely Resolved; 2 = Much Better But Still Present; 3 = Little Bit Better, But Still Present; 4 = Unchanged, 5 = Getting Worse) at Baseline
|
3.0 units on a scale
Standard Deviation 1.5
|
4.0 units on a scale
Standard Deviation 0.0
|
3.3 units on a scale
Standard Deviation 1.3
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only participants not being cognitively impaired were able to answer the questionnaires (in total n = 32/133 at baseline).
Self-completion of the 5-D itch scale. Question 4: 1=Never affects sleep;2=Occasionally delays falling asleep;3=Frequently delays falling asleep;4=Delays falling asleep and occasionally wakes me up;5=Delays falling asleep and frequently wakes me up at night. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=12 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=9 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=11 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 4. Affecting of Sleep (See Score Informations in the Outcome Measure Description) at Baseline
|
1.2 units on a scale
Standard Deviation 0.6
|
1.2 units on a scale
Standard Deviation 0.7
|
1.4 units on a scale
Standard Deviation 0.5
|
SECONDARY outcome
Timeframe: BaselinePopulation: Only participants not being cognitively impaired were able to answer the questionnaires (in total n = 32/133 at baseline). One value in the Cetaphil Group is missing for this question.
Self-completion of the 5-D itch scale. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=10 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 5. Affecting of Daily Activities ( 1 = Never Affects Activity; 2 = Rarely Affects Activity; 3 = Occasionally Affects Activity; 4 = Frequently Affects Activity; 5 = Always Affects Activity) at Baseline
|
1.1 units on a scale
Standard Deviation 0.3
|
1.4 units on a scale
Standard Deviation 0.7
|
1.6 units on a scale
Standard Deviation 0.7
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only participants not being cognitively impaired were able to answer the questionnaires. Due to a number of loss to follow up at the end of the study, n = 28/117 answer these question. In the Excipial Group one value is missing for that question.
Self-completion of the 5-D itch scale. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=7 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 1. Hours of Itching (1 = Less Than 6hours/Day; 2 = 6-12 Hours/Day; 3 = 12-18 Hours/Day; 4 = 18-23hours/Day; 5 = All Day) at Day 56 +/-3
|
1.0 units on a scale
Standard Deviation 0.0
|
1.1 units on a scale
Standard Deviation 0.4
|
1.0 units on a scale
Standard Deviation 0.0
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only participants not being cognitively impaired were able to answer the questionnaires. Due to a number of loss to follow up at the end of the study, n = 28/117 answer these question.
Self-completion of the 5-D itch scale. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 2. Itch Intensity (1 = Not Present; 2 = Mild; 3 = Moderate; 4 = Severe; 5 = Unbearable) at Day 56 +/-3
|
1.7 units on a scale
Standard Deviation 1.0
|
1.8 units on a scale
Standard Deviation 0.7
|
1.9 units on a scale
Standard Deviation 0.9
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only participants not being cognitively impaired were able to answer the questionnaires. Due to a number of loss to follow up at the end of the study, n = 28/117 answer these question.
Self-completion of the 5-D itch scale. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 3. Changes in Intensity of Itch (Past Two Weeks). (1 = Completely Resolved; 2 = Much Better But Still Present; 3 = Little Bit Better, But Still Present; 4 = Unchanged, 5 = Getting Worse) at Day 56 +/-3
|
2.8 units on a scale
Standard Deviation 1.8
|
2.9 units on a scale
Standard Deviation 1.6
|
3.3 units on a scale
Standard Deviation 1.6
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only participants not being cognitively impaired were able to answer the questionnaires. Due to a number of loss to follow up at the end of the study, n = 28/117 answer these question.
Self-completion of the 5-D itch scale. Question 4: 1=Never affects sleep;2=Occasionally delays falling asleep;3=Frequently delays falling asleep;4=Delays falling asleep and occasionally wakes me up;5=Delays falling asleep and frequently wakes me up at night. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=11 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 4. Affecting of Sleep (See Score Details in the Outcome Measure Description) at Day 56 +/-3
|
1.2 units on a scale
Standard Deviation 0.4
|
1.0 units on a scale
Standard Deviation 0.0
|
1.2 units on a scale
Standard Deviation 0.4
|
SECONDARY outcome
Timeframe: Day 56 +/-3Population: Only participants not being cognitively impaired were able to answer the questionnaires. Due to a number of loss to follow up at the end of the study, n = 28/117 answer these question. In the Cetaphil Group one value is missing for that question.
Self-completion of the 5-D itch scale. Having a 6-CIT score of 7 or lower was the criterion to administer the 5-D itch scale.The score of the 5-D Itch scale ranges from '5' (no pruritus) to '25' (most severe pruritus) and contains five items measuring pruritus over the past two weeks. A possible cognitive impairment was tested using the Six Item Cognitive Impairment Test on Day 0. It includes six simple questions, for example 'What year is it?' or 'Count backwards from 20 to 10. Scores may range from 0 (= no sign of cognitive impairment) to a maximum score of 28 (= significant cognitive impairment). Residents with sum scores \> 8 were classified as 'cognitively impaired'.
Outcome measures
| Measure |
Cetaphil® Restoraderm
n=10 Participants
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=8 Participants
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=9 Participants
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Itch Assessment. Question 5. Affecting of Daily Activities ( 1 = Never Affects Activity; 2 = Rarely Affects Activity; 3 = Occasionally Affects Activity; 4 = Frequently Affects Activity; 5 = Always Affects Activity) at Day 56 +/-3
|
1.2 units on a scale
Standard Deviation 0.4
|
1.1 units on a scale
Standard Deviation 0.4
|
1.3 units on a scale
Standard Deviation 0.5
|
Adverse Events
Cetaphil® Restoraderm
Excipial
Standard Skin Care
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Cetaphil® Restoraderm
n=45 participants at risk
Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks
Cetaphil® Restoraderm
|
Excipial
n=44 participants at risk
Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks
Excipial
|
Standard Skin Care
n=44 participants at risk
Usual skin care routine of the nursing home resident
|
|---|---|---|---|
|
Skin and subcutaneous tissue disorders
Itch and redness on arms
|
2.2%
1/45 • Number of events 1 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
0.00%
0/44 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
0.00%
0/44 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
|
Skin and subcutaneous tissue disorders
Erythema face
|
2.2%
1/45 • Number of events 1 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
0.00%
0/44 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
0.00%
0/44 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
|
Skin and subcutaneous tissue disorders
Redness, irritation at the whole body
|
2.2%
1/45 • Number of events 1 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
0.00%
0/44 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
0.00%
0/44 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
|
Skin and subcutaneous tissue disorders
Skin dryness at the back
|
0.00%
0/45 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
2.3%
1/44 • Number of events 1 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
0.00%
0/44 • Undesirable effects, defined as any adverse reaction clearly linked to the normal or reasonably foreseeable use of a cosmetic product, were monitored from the time informed consent was obtained until study completion, an average of 10 weeks. All subjects experiencing undesirable effects were monitored until symptoms subsided, or until there was a satisfactory explanation for the changes observed.
The intensity of the undesirable effect was described in terms of mild, moderate or severe.
|
Additional Information
PD Dr. Jan Kottner
Charité Universitätsmedizin Berlin, Germany
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place